Torsemide Versus Furosemide in Patients With Acute Heart Failure (from the ASCEND-HF Trial)
- 1 February 2016
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 117 (3) , 404-411
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- The Diuretic Torasemide Does Not Prevent Aldosterone-Mediated Mineralocorticoid Receptor Activation in CardiomyocytesPLOS ONE, 2013
- Role of lysyl oxidase in myocardial fibrosis: from basic science to clinical aspectsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2010
- Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity‐score matched samplesStatistics in Medicine, 2009
- Beneficial Effects of Torasemide on Systolic Wall Stress and Sympathetic Nervous Activity in Asymptomatic or Mildly Symptomatic Patients With Heart Failure: Comparison With AzosemideJournal of Cardiovascular Pharmacology, 2009
- Impact of Treatment on Myocardial Lysyl Oxidase Expression and Collagen Cross-Linking in Patients With Heart FailureHypertension, 2009
- Using Inverse Probability-Weighted Estimators in Comparative Effectiveness Analyses With Observational DatabasesMedical Care, 2007
- Effects of torasemide on cardiac sympathetic nerve activity and left ventricular remodelling in patients with congestive heart failureHeart, 2006
- Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)American Heart Journal, 2005
- Stratification and weighting via the propensity score in estimation of causal treatment effects: a comparative studyStatistics in Medicine, 2004
- Effects of loop diuretics on myocardial fibrosis and collagen type I turnover in chronic heart failureJACC, 2004